We propose that direct activation of the NFκB pathway may be an efficient strategy for differentiating glioblastoma-initiating cells to maintain their proliferative potential, and blockade of this transcriptional pathway drives tumor cells into senescence. The gene discussed is NFKB1; the disease is neoplasm.